Global Ambulatory Polysomnography (Psg) Systems Market is valued approximately at USD 346.6 million in 2022 and is anticipated to grow with a growth rate of more than 1.5% over the forecast period 2023-2030. The ambulatory polysomnography (PSG) system is designed to provide portable diagnostic devices and associated services that allow for the monitoring and analysis of sleep patterns and physiological parameters in patients outside of a conventional sleep laboratory. The ambulatory polysomnography psg system market is driven by factors such as increasing demand for portable and home PSG devices and increasing cases of sleeping disorder. These systems help identify and analyse the sleeping pattern of patient out the conventional sleep laboratory According to sleep foundation estimates, 50 million to 70 million people in the U.S. have ongoing sleep disorders along with that 76% U.S adults facing disorder and along with that according to statista the sleeping disorder cases registered in Spain in year 2021 was 4,041, 527.Thus rising in sleeping disorder cases fueling the growth of the market. In addition the use of AI in PSG system and large undiagnosed population may create the lucrative opportunities for the market. However, the lack of awareness about sleeping disorder may hinder the growth of the market.
The key regions considered for the Global Ambulatory Polysomnography (Psg) Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to increasing cases of sleeping disorder.And Europe is considered as the fastest growing region during the forecasted period due to the presence of multiple manufacturers & high level of awareness about sleeping disorder and rising healthcare expenditure.
Major market players included in this report are:
- Koninklijke Philips N.V
- Natus Medical Incorporated
- Nihon kohden corporation
- NoxMedical
- Lowenstein medical technology Gmbh +co..KG
- Neurosoft
- Cadwell industries Inc.
- Somnomedics Gmbh
- Compumedics Ltd.
- Onera technologies B.V
Recent Developments in the Market:
- In august 2020, Somnomedics Gmbh recived FDA approval for use of Somnoscreen HD,Somnoscreen plus ,and Somnoscreen eco in the pediatric population as younger as 2 years old.
- In july 2019 ,natus medical incorporated oprnd a new distribution center in Galway, Irland it ia a 22000sq foot facility and expanded thr existing Natus facility in Gort over 66000sq foot.
Global Ambulatory Polysomnography (Psg) Systems Market Report Scope:
- Historical Data: 2020 - 2021
- Base Year for Estimation: 2022
- Forecast period: 2023-2030
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Product, Application, End User, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
- Up to 12 Channel PSG Systems
- Up to 24 Channel PSG Systems
- Up to 32 Channel PSG Systems
- Above 32 Channel PSG Systems
By Application:
- Obstructive Sleep Apnea
- Narcolepsy
- Chronic Insomnia
- Others
By End User:
- Hospitals
- Sleep Laboratories
- Home Care Settings
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
- 1.2.1. Ambulatory Polysomnography (Psg) Systems Market, by region, 2020-2030 (USD Million)
- 1.2.2. Ambulatory Polysomnography (Psg) Systems Market, by Product, 2020-2030 (USD Million)
- 1.2.3. Ambulatory Polysomnography (Psg) Systems Market, by Application, 2020-2030 (USD Million)
- 1.2.4. Ambulatory Polysomnography (Psg) Systems Market, by End user, 2020-2030 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Ambulatory Polysomnography (Psg) Systems Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Ambulatory Polysomnography (Psg) Systems Market Dynamics
- 3.1. Ambulatory Polysomnography (Psg) Systems Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing demand for portable and home PSG devices.
- 3.1.1.2. Increasing cases of sleeping disorder.
- 3.1.2. Market Challenges
- 3.1.2.1. Lack of awareness about sleeping disorder
- 3.1.2.2. Technological complexity
- 3.1.3. Market Opportunities
- 3.1.3.1. The use of AI in PSG system
- 3.1.3.2. Large undiagnosed population
Chapter 4. Global Ambulatory Polysomnography (Psg) Systems Market: Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Impact Analysis
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economic
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. COVID-19 Impact Analysis
- 4.7. Disruptive Trends
- 4.8. Industry Expert Perspective
- 4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Ambulatory Polysomnography (Psg) Systems Market, by Product
- 5.1. Market Snapshot
- 5.2. Global Ambulatory Polysomnography (Psg) Systems Market by Product, Performance - Potential Analysis
- 5.3. Global Ambulatory Polysomnography (Psg) Systems Market Estimates & Forecasts by Product 2020-2030 (USD Million)
- 5.4. Ambulatory Polysomnography (Psg) Systems Market, Sub Segment Analysis
- 5.4.1. Up to 12 channel PSG system
- 5.4.2. Up to 24 channel PSG system
- 5.4.3. Up to 32 channel PSG system
- 5.4.4. Above 32 channel PSG sysrtem
Chapter 6. Global Ambulatory Polysomnography (Psg) Systems Market, by Application
- 6.1. Market Snapshot
- 6.2. Global Ambulatory Polysomnography (Psg) Systems Market by Application, Performance - Potential Analysis
- 6.3. Global Ambulatory Polysomnography (Psg) Systems Market Estimates & Forecasts by Application 2020-2030 (USD Million)
- 6.4. Ambulatory Polysomnography (Psg) Systems Market, Sub Segment Analysis
- 6.4.1. Obstructive sleep Apnea
- 6.4.2. Narcolepsy
- 6.4.3. Chronic Insomnia
- 6.4.4. Other
Chapter 7. Global Ambulatory Polysomnography (Psg) Systems Market, by End user
- 7.1. Market Snapshot
- 7.2. Global Ambulatory Polysomnography (Psg) Systems Market by End user, Performance - Potential Analysis
- 7.3. Global Ambulatory Polysomnography (Psg) Systems Market Estimates & Forecasts by End user 2020-2030 (USD Million)
- 7.4. Ambulatory Polysomnography (Psg) Systems Market, Sub Segment Analysis
- 7.4.1. Hospital
- 7.4.2. Sleep Laboratories
- 7.4.3. Home care setting
Chapter 8. Global Ambulatory Polysomnography (Psg) Systems Market, Regional Analysis
- 8.1. Top Leading Countries
- 8.2. Top Emerging Countries
- 8.3. Ambulatory Polysomnography (Psg) Systems Market, Regional Market Snapshot
- 8.4. North America Ambulatory Polysomnography (Psg) Systems Market
- 8.4.1. U.S. Ambulatory Polysomnography (Psg) Systems Market
- 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
- 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
- 8.4.1.3. End user breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Ambulatory Polysomnography (Psg) Systems Market
- 8.5. Europe Ambulatory Polysomnography (Psg) Systems Market Snapshot
- 8.5.1. U.K. Ambulatory Polysomnography (Psg) Systems Market
- 8.5.2. Germany Ambulatory Polysomnography (Psg) Systems Market
- 8.5.3. France Ambulatory Polysomnography (Psg) Systems Market
- 8.5.4. Spain Ambulatory Polysomnography (Psg) Systems Market
- 8.5.5. Italy Ambulatory Polysomnography (Psg) Systems Market
- 8.5.6. Rest of Europe Ambulatory Polysomnography (Psg) Systems Market
- 8.6. Asia-Pacific Ambulatory Polysomnography (Psg) Systems Market Snapshot
- 8.6.1. China Ambulatory Polysomnography (Psg) Systems Market
- 8.6.2. India Ambulatory Polysomnography (Psg) Systems Market
- 8.6.3. Japan Ambulatory Polysomnography (Psg) Systems Market
- 8.6.4. Australia Ambulatory Polysomnography (Psg) Systems Market
- 8.6.5. South Korea Ambulatory Polysomnography (Psg) Systems Market
- 8.6.6. Rest of Asia Pacific Ambulatory Polysomnography (Psg) Systems Market
- 8.7. Latin America Ambulatory Polysomnography (Psg) Systems Market Snapshot
- 8.7.1. Brazil Ambulatory Polysomnography (Psg) Systems Market
- 8.7.2. Mexico Ambulatory Polysomnography (Psg) Systems Market
- 8.8. Middle East & Africa Ambulatory Polysomnography (Psg) Systems Market
- 8.8.1. Saudi Arabia Ambulatory Polysomnography (Psg) Systems Market
- 8.8.2. South Africa Ambulatory Polysomnography (Psg) Systems Market
- 8.8.3. Rest of Middle East & Africa Ambulatory Polysomnography (Psg) Systems Market
Chapter 9. Competitive Intelligence
- 9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
- 9.2. Top Market Strategies
- 9.3. Company Profiles
- 9.3.1. Koninklijke Philips N.V
- 9.3.1.1. Key Information
- 9.3.1.2. Overview
- 9.3.1.3. Financial (Subject to Data Availability)
- 9.3.1.4. Product Summary
- 9.3.1.5. Recent Developments
- 9.3.2. Natus Medical Incorporated
- 9.3.3. Nihon kohden corporation
- 9.3.4. NoxMedical
- 9.3.5. Lowenstein medical technology Gmbh +co..KG
- 9.3.6. Neurosoft
- 9.3.7. Cadwell industries Inc.
- 9.3.8. Somnomedics Gmbh
- 9.3.9. Compumedics Ltd.
- 9.3.10. Onera technologies B.V
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption